In addition, MSI2 seems to be involved in patients’ prognosis, resulting as prognostic factor in gastric [8] and cervical cancer [9]; in lung cancer, MSI2 emerged as a novel therapeutic target [10]. This evidence concerns the gene MSI2 and cervical carcinoma.